REGISTERED NUMBER: 12173816 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2024

FOR

MACULA CARE LIMITED

Page

Balance Sheet

1

FIXED ASSETS

27,600

34,397

CURRENT ASSETS

191,621

151,404

CREDITORS

Amounts falling due within one year

(7,229

)

(17,725

)

NET CURRENT ASSETS

184,392

133,679

TOTAL ASSETS LESS CURRENT LIABILITIES

211,992

168,076

CAPITAL AND RESERVES

211,992

168,076

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Macula Care Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

12173816

Registered office:

Rex Buildings

Alderley Road

Wilmslow

Cheshire

SK9 1HY

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2023 - 2 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 7 April 2025 and were signed by:

Mr S Pagliarini - Director